Recap of Oncolytics Biotech Q4 Earnings
Oncolytics Biotech (NASDAQ: ONCY) unveiled its Q4 earnings on March 7, 2024, at 04:00 PM. Let’s delve into the highlights of the announcement:
Earnings Update:
Surpassed estimated earnings by a substantial 64.0%, with an EPS of $-0.04 exceeding the projected $-0.11.
Revenue held steady compared to the same period last year.
Previous Earnings Performance:
In the prior quarter, the company fell short on EPS by $0.0, leading to a 4.0% decline in share price the next day.
For a comprehensive overview and to keep track of all earnings releases from Oncolytics Biotech, you can refer to their earnings calendar.
Stay informed with insights from a variety of sources such as Zacks, TipRanks, Nasdaq, and Yahoo Finance.
ONCY Stock Sees Slight Uptick in After-Hours Trading on March 7, 2024
ONCY stock had a relatively uneventful day on March 7, 2024, as it traded flat throughout the regular trading hours. The stock closed at $1.04, which was unchanged from the previous trading session. However, in after-hours trading, ONCY saw a slight uptick, with the stock rising $0.03 to $1.07.
Investors may be keeping a close eye on ONCY’s performance, as the stock’s price change of 0.00% on March 7th may indicate a period of consolidation or stability. However, the slight increase in after-hours trading could potentially signal some positive momentum for the stock in the near term.
ONCY Stock Performance Analysis: Mixed Results on March 7, 2024
ONCY stock had a mixed performance on March 7, 2024, as investors digested the latest financial data released by the company. Despite the lack of information on total revenue, the net income figures provided some insights into the company’s financial health.
According to CNN Money, ONCY reported a net income of -$19.08 million over the past year, which represents a 9.08% increase compared to the previous year. However, the net income for the third quarter of the fiscal year was -$7.40 million, indicating a 33.56% decrease compared to the previous quarter.
Earnings per share (EPS) also showed a similar trend, with a reported EPS of -$0.33 for the past year, reflecting a 16.17% increase compared to the previous year. However, the EPS for the third quarter was -$0.11, marking a 23.4% decrease compared to the previous quarter.
These financial figures suggest that ONCY has been able to improve its net income and EPS on a yearly basis, but has experienced a decline in performance in the most recent quarter. This mixed performance may have contributed to the fluctuation in ONCY stock prices on March 7, 2024.
Investors and analysts will likely be closely monitoring ONCY’s financial performance in the coming quarters to assess the company’s ability to maintain and improve its profitability. The lack of information on total revenue adds an element of uncertainty to the overall picture, making it important for stakeholders to stay informed and vigilant in their investment decisions related to ONCY stock.
